Irritation-reducing ocular ionthophoretic device
Details for Australian Patent Application No. 2005247122 (hide)
International Classifications
Event Publications
14 December 2006 PCT application entered the National Phase
PCT publication WO2005/115281 Priority application(s): WO2005/115281
19 April 2007 Change of Name(s) of Applicant(s), Section 104
Optis France The name of the applicant has been changed to Eyegate Pharma S.A.
21 January 2010 Application Accepted
Published as AU-B-2005247122
20 May 2010 Standard Patent Sealed
22 September 2011 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 06 Sep 2011. Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000
29 September 2011 Application for Amendment
The nature of the amendment is: Amend the invention title to read Irritation-reducing ocular iontophoretic device. Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000
2 February 2012 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 06 Sep 2011
9 February 2012 Amendment Made
The nature of the amendment is: Amend the invention title to read Irritation-reducing ocular iontophoretic device 2006
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005247140-Absorbable biocompatible materials
2005247114-Use of neboglamine (CR 2249) as an antipsychotic and neuroprotective
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser